Observational studyCardiovascular diabetology2025
Triglyceride glucose index in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study.
Observational study in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Synergistic effects of insulin resistance and revascularization completeness on prognosis in patients with coronary artery calcification.Cardiovascular diabetology · 2026Observational
- Article
- Association of the C-reactive protein-triglyceride-glucose index with the risk of incident cardiovascular disease in rectal cancer survivors.Frontiers in cardiovascular medicine · 2026Article
- Association between triglyceride-glucose index-a body shape index and atherosclerotic cardiovascular disease, and the modification effect of dietary patterns.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEmerging evidence has highlighted the connection between the Triglyceride-glucose (TyG) index and the development and severity of coronary artery disease. However, the role of the TyG index in predicting adverse cardiovascular outcomes among patients who have undergone percutaneous coronary intervention (PCI) remains underexplored.
methodsOur study encompassed 8019 individuals with acute coronary syndrome (ACS) who had PCI, sourced from the ongoing perspective, observational, single-center COSTIC research. We gathered data on baseline clinical characteristics and the TyG index. The primary endpoints were major adverse cardiovascular events (MACE), which included cardiovascular death, all-cause death, myocardial infarction, and stroke. To examine the relationship between the TyG index and cardiovascular outcomes, we utilized multivariate Cox proportional hazards models and restricted cubic splines.
resultsDuring the 1-year follow-up period, we documented 341 MACEs, comprising 197 cardiovascular deaths and 242 all-cause deaths. The TyG index was associated with a higher risk of MACE (hazard ratio [HR]: 1.246, 95% confidence interval [CI] 1.064 to 1.459, p = 0.006), cardiovascular death (HR: 1.409, 95% CI 1.150 to 1.727, p = 0.001) and all-cause death (HR: 1.368, 95% CI 1.133 to 1.652, p = 0.001) for each interquartile range (IQR) increment. Stratified analyses unveiled significant interactions between the TyG index and variables such as sex, smoking status, and ACS diagnosis (p for interaction < 0.05). Nevertheless, restricted cubic splines analysis did not detect a non-linear relationship between the TyG index and MACE (p-non-linear = 0.971), cardiovascular mortality (p-non-linear = 0.684), or all-cause mortality (p-non-linear = 0.827).
conclusionsOur findings underscore a significant association between the TyG index and adverse cardiovascular outcomes, including cardiovascular and all-cause mortality, in ACS patients following PCI. The TyG index may thus function as an early predictor of cardiovascular risk or a potential therapeutic target in the management of cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.